CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Completed BsUFA III Deliverables

RegulatoryNeutral
AI Analysis

Summary

The FDA has completed BsUFA III deliverables. User fees have expedited biosimilar product review processes since the Biosimilar User Fee Act's passage in 2012.

Importance:2/10
Sentiment:
0.00
BsUFAbiosimilaruser feesFDA review process

Read the original article

Published by FDA Drugs (New Approvals & NDA) on August 13, 2026 8:11 PM

Read Original